secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORTHOPEDIATRICS CORP (KIDS)
CIK:        0001425450
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001425450-24-000002
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OrthoPediatrics prelim Q4 revenue $37.6M (+21%); acquires Boston O&P; 2024 guidance $197-200M
--------------------------------------------------------------------------------

- Preliminary Q4 2023 net revenue $37.6M (up 21% YoY); full year $148.7M (up 22%).
- Domestic Q4 rev $28.3M (+24%), int'l $9.3M (+13%). FY domestic $111.0M (+20%), int'l $37.7M (+26%).
- Acquired Boston O&P on Jan 5, 2024 (annual revenue ~$25M); deal expected accretive to adjusted EBITDA in 2024.
- 2024 revenue guidance $197M-$200M (32-34% growth). Cash ~$60M post-acquisition; new $30M term + $50M revolver.
- Acquisition of Boston O&P was also a customer/supplier; Q4 helped ~20k kids, cumulative >710k.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1425450/000142545024000002/0001425450-24-000002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1425450/000142545024000002/kids-20240108.htm
  HTML page:      https://secwatch.observer/filing/0001425450-24-000002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer